ProBiotix Health Plc (AQU:PBX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
8.50
0.00 (0.00%)
At close: Feb 11, 2025

ProBiotix Health Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
2.131.671.121.10.820.37
Revenue Growth (YoY)
70.65%49.19%1.93%33.98%123.60%-
Cost of Revenue
0.960.80.480.550.310.1
Gross Profit
1.170.870.640.550.510.27
Selling, General & Admin
1.641.580.720.450.460.39
Research & Development
-----0.18
Other Operating Expenses
-----0.13
Operating Expenses
1.691.630.760.450.460.7
Operating Income
-0.52-0.76-0.120.110.05-0.43
Interest Expense
--0.01-0.06-0.06-0.05
Interest & Investment Income
--0.06---
Other Non Operating Income (Expenses)
---0.17---
Pretax Income
-0.52-0.76-0.220.04-0.01-0.49
Income Tax Expense
-0.02-0.020.010.01-0.04
Net Income
-0.5-0.75-0.230.04-0.01-0.52
Net Income to Common
-0.5-0.75-0.230.04-0.01-0.52
Shares Outstanding (Basic)
1221229000-
Shares Outstanding (Diluted)
1221229000-
Shares Change (YoY)
23.88%34.59%90298.56%---
EPS (Basic)
-0.00-0.01-0.000.36-0.13-
EPS (Diluted)
-0.00-0.01-0.000.36-0.13-
Free Cash Flow
-1.11-0.24-0.62-0-0.41
Free Cash Flow Per Share
-0.01-0.00-0.01-0.01-
Gross Margin
55.10%52.12%57.10%50.44%61.90%72.74%
Operating Margin
-24.35%-45.55%-11.01%9.62%5.62%-117.94%
Profit Margin
-23.32%-44.65%-20.66%3.30%-1.62%-142.48%
Free Cash Flow Margin
-52.28%-14.23%-55.03%-0.10%-112.91%
EBITDA
-0.47-0.71-0.09---
EBITDA Margin
-21.96%-42.38%-8.18%---
D&A For EBITDA
0.050.050.03---
EBIT
-0.52-0.76-0.120.110.05-0.43
EBIT Margin
-24.35%-45.55%-11.01%9.62%5.62%-117.94%
Effective Tax Rate
---15.16%--
Source: S&P Capital IQ. Standard template. Financial Sources.